MDXG
-
Financial
MiMedx Announces 2015 Record Results
COMPANY RECORDS REVENUE OF $187.3 MILLION, NET INCOME OF $29.4 MILLION AND EPS OF $0.28 (BASIC) AND $0.26 (DILUTED) MARIETTA,…
Read More » -
Hospitals
MiMedx Group (MDXG) Announces Favorable PTAB Ruling for EpiFix and AmnioFix Patents
MiMedx Group, Inc. (NASDAQ: MDXG) announced today the Patent Trial and Appeal Board (“PTAB”) has ruled in favor of the Company’s…
Read More » -
Financial
MiMedx Group Lifted to Strong-Buy at Zacks (MDXG)
By Robert Jamerson Zacks upgraded shares of MiMedx Group (NASDAQ:MDXG) from a hold rating to a strong-buy rating in a report issued on…
Read More » -
Financial
MiMedx Reports Record First Quarter 2015 Revenue of $40.8 Million
MARIETTA, Ga., April 13, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Hospitals
MiMedx Group Inc. (NASDAQ:MDXG) received notice from the Department of Justice
By Joel Rizzo (PR Newswire)MiMedx Group Inc. (NASDAQ:MDXG) the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More »